Hims Launches Testosterone Replacement Therapy Service

The company is offering remote clinical assessments and treatments for men experiencing testosterone deficiency.

Updated on Oct. 21, 2026 in Men’s Health

Bold vector editorial illustration of a sterile medical blood collection device on a wooden surface, representing modern telehealth diagnostic services.
Hims has introduced a new testosterone replacement therapy service, incorporating remote clinical assessments and at-home blood testing to improve patient access. AI Illustration. Upload story photo >

Live Poll

Would you trust a telehealth platform to manage your hormone replacement therapy and medical testing?

Hims has introduced a new testosterone replacement therapy service that utilizes remote clinical assessments and at-home blood testing. The platform aims to improve access for patients struggling with testosterone deficiency across the United States.

Why it matters

The move seeks to bridge the gap in men's health access by streamlining the diagnostic process for a condition linked to significant long-term health outcomes. By leveraging telemedicine, the company intends to simplify how patients receive consultations and prescribed care.

The service utilizes a Tasso blood collection device to analyze 21 different biomarkers for hormone testing. This follows a company-commissioned survey of 2,000 American men regarding health priorities.

The players

Hims

Hims is a telehealth company founded in 2017 that focuses on providing direct-to-consumer medical treatments for various men's and women's health conditions.

The details

Patients must complete a synchronous video chat with a clinician, who reviews medical history and symptoms alongside bloodwork results generated by the Tasso capillary test. The service provides access to two types of injectable treatments as well as an oral pill, all of which are managed under the regulatory framework of the 1990 Anabolic Steroids Control Act.

Timeline

  1. 1990: Testosterone became a controlled substance.

  2. 2017: Hims launched operations.

  3. 2022: Researchers tested digital clinic prescription practices.

  4. Summer 2026: Hims commissioned a survey of 2,000 American men.

  5. October 2026: Hims launched the testosterone replacement therapy service.

Health Landscape

The service must operate within the strict regulatory framework established by the 1990 Anabolic Steroids Control Act. This expansion reflects a broader trend of digitizing specialized hormone treatments that were previously confined to traditional in-person medical settings.

Patients can now potentially bypass traditional clinic wait times by utilizing the remote diagnostic process involving video chats and at-home blood collection. However, users should be aware that treatment involves controlled substances that require ongoing clinical supervision.

The takeaway

Men concerned about symptoms of low testosterone should consult a healthcare provider to discuss whether hormonal therapy is appropriate for their specific medical history. Understanding your baseline hormone levels is a critical first step before considering any medical intervention.

Further reading

For more information on current wellness trends, visit the Men’s Health section.

Live Poll

Would you trust a telehealth platform to manage your hormone replacement therapy and medical testing?